• Verkeerd document? Gratis ruilen
  • Geschreven door studenten die geslaagd zijn
  • Direct beschikbaar na je betaling
  • Online lezen of als PDF
Verkopen
Kies je studieland
Kies je taal
Document preview thumbnail
Voorbeeld 4 van de 45 pagina's
Tentamen (uitwerkingen)

NURS 6501-ADVANCED PATHOPHYSIOLOGY EXAM 2026 LATEST UPDATE QUESTIONS AND CORRECT VERIFIED ANSWERS ALREADY GRADED A+

Document preview thumbnail
Voorbeeld 4 van de 45 pagina's

NURS 6501-ADVANCED PATHOPHYSIOLOGY EXAM 2026 LATEST UPDATE QUESTIONS AND CORRECT VERIFIED ANSWERS ALREADY GRADED A+

Voorbeeld van de inhoud

NURS 6501-ADVANCED PATHOPHYSIOLOGY EXAM
2026 LATEST UPDATE QUESTIONS AND CORRECT
VERIFIED ANSWERS ALREADY GRADED A+

ALL vs CLL - ANS-Acute lymphoblastic leukemia is more common than chronic.



Leukemia demographics - ANS-Whites are more affected by leukemia than blacks.



Acute leukemia - ANS-Presence of >30% lymphoblasts in blood or marrow.



Chronic leukemia - ANS-Mature cells present but function abnormally.



Thrombocytopenia - ANS-Decreased platelet production or increased destruction.



Pseudothrombocytopenia - ANS-Platelet clumping causes falsely low counts.



Blood transfusion effect - ANS->10 units in 24 hours can falsely diagnose thrombocytopenia.



Diagnosing thrombocytopenia - ANS-Requires clinical symptoms and blood tests.



Thrombocytopenia lab results - ANS-Platelet count <150,000 indicates thrombocytopenia.



Platelet count <50,000 - ANS-Risk of hemorrhage from minor trauma.



Platelet count 10-20,000 - ANS-Spontaneous bleeding occurs without trauma.

,Platelet count <10,000 - ANS-Severe bleeding risk, can be fatal.



Clinical manifestations of thrombocytopenia - ANS-Begin at platelet counts of 30,000-15,000.



Symptoms of thrombocytopenia - ANS-Includes petechiae, purpura, and frequent nosebleeds.



Sickle cell disorder - ANS-Causes misshapen red blood cells and hemolysis.



Sickle cell triggers - ANS-Hypoxemia, acidosis, dehydration, and low temperature.



Sickled erythrocyte recovery - ANS-Regain normal shape after reoxygenation and rehydration.



Sickling pathophysiology - ANS-Involves chronic hemolysis and microvascular occlusions.



Megaloblastic anemia - ANS-Large immature RBCs from vitamin B12 or folate deficiency.



RNA synthesis in megaloblastic anemia - ANS-Occurs normally, causing unequal growth of
nucleus and cytoplasm.



Types of megaloblastic anemia - ANS-Includes folate deficiency and vitamin B12 deficiency.



Clinical manifestations of anemia - ANS-General symptoms include fatigue, pallor, and
weakness.



Fatigue - ANS-Common symptom of anemia indicating low energy.

,Dyspnea - ANS-Shortness of breath often associated with anemia.



Elevated HR - ANS-Increased heart rate due to anemia-induced hypoxia.



Cardiac dilation - ANS-Heart enlargement due to volume overload.



Heart valve insufficiency - ANS-Inadequate valve function leading to heart failure.



Pernicious anemia - ANS-Macrocytic anemia from vitamin B12 deficiency.



Intrinsic factor - ANS-Protein necessary for B12 absorption in intestines.



DIC - ANS-Disseminated intravascular coagulation causing simultaneous clotting and bleeding.



Cancer - ANS-Potential cause of DIC through tissue factor release.



Sepsis - ANS-Systemic infection that can trigger DIC.



Thrombin activity - ANS-Increased in DIC, leading to excessive clot formation.



Fibrinolysis - ANS-Process of breaking down clots, accelerated in DIC.



Organ hypoperfusion - ANS-Reduced blood flow to organs due to clotting.



Multiple myeloma - ANS-B-cell cancer affecting bone marrow and causing lesions.

, IgG - ANS-Antibody produced in excess by malignant plasma cells.



Cytokines - ANS-Signaling proteins like interleukin 6 that regulate myeloma.



M protein - ANS-Abnormal antibody prevalent in multiple myeloma patients.



Bence Jones proteins - ANS-Light chains damaging renal tubular cells in myeloma.



Tuberculosis (TB) - ANS-Airborne disease caused by Mycobacterium tuberculosis.



Opportunistic infection - ANS-Infection more likely in immunocompromised individuals.



At-risk populations for TB - ANS-Individuals with weakened immune systems or poor health.



Pallor - ANS-Pale skin indicating possible anemia or hypoxia.



Paresthesia - ANS-Abnormal sensation often linked to neurological issues.



Low-income countries - ANS-Regions with limited healthcare resources, high disease rates.



Acute epiglottitis - ANS-Rapid inflammation of the epiglottis, potentially life-threatening.



Haemophilus influenza type B - ANS-Bacteria causing acute epiglottitis, preventable by
vaccination.



Children ages 2-7 - ANS-Most affected demographic for acute epiglottitis.

Documentinformatie

Geüpload op
17 september 2026
Aantal pagina's
45
Geschreven in
2026/2027
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden
€22,53

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Verkocht
1
Volgers
0
Items
255
Laatst verkocht
10 maanden geleden

Echte notities, van echte studenten
Elk document op Stuvia is geschreven door een medestudent die hetzelfde vak deed. Zo leer je van iemand die het al heeft gehaald.



Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen